Pericholangitis.
Amini A, Nagalli S.
2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Pericholangitis in patients with ulcerative colitis, and risk factors for progression to colorectal cancer.
Levine DS.
Am J Gastroenterol. 1993 Aug;88(8):1151-4.
Elucidation of pericholangitis and periductal fibrosis in cholestatic liver diseases via extracellular vesicles released by polarized biliary epithelial cells.
Maki K, Katsumi T, Hanatani T, Uchiyama F, Suzuki F, Hoshikawa K, Haga H, Saito T, Ueno Y.
Am J Physiol Cell Physiol. 2024 Apr 1;326(4):C1094-C1105. doi: 10.1152/ajpcell.00655.2023. Epub 2024 Feb 12.
Chronic postcolectomy pericholangitis and cholangiocarcinoma.
Morowitz DA, Benbassat RH.
J Clin Gastroenterol. 1985 Aug;7(4):323-6. doi: 10.1097/00004836-198508000-00011.
The liver in ulcerative colitis; treatment of pericholangitis with tetracycline.
RANKIN JG, BODEN RW, GOULSTON SJ, MORROW W.
Lancet. 1959 Dec 19;2(7112):1110-2. doi: 10.1016/s0140-6736(59)90098-4.
PERICHOLANGITIS AND ULCERATIVE COLITIS. II. CLINICAL ASPECTS.
MISTILIS SP, SKYRING AP, GOULSTON SJ.
Ann Intern Med. 1965 Jul;63:17-26. doi: 10.7326/0003-4819-63-1-17.
Pericholangitis in a rabbit colitis model induced by injection of muramyl dipeptide emulsified with a long-chain fatty acid.
Kuroe K, Haga Y, Funakoshi O, Kanazawa K, Mizuki I, Yoshida Y.
J Gastroenterol. 1996 Jun;31(3):347-52. doi: 10.1007/BF02355023.
PERICHOLANGITIS AND ULCERATIVE COLITIS. I. PATHOLOGY, ETIOLOGY, AND PATHOGENESIS.
MISTILIS SP.
Ann Intern Med. 1965 Jul;63:1-16. doi: 10.7326/0003-4819-63-1-1.
[Pericholangitis and primary sclerosing cholangitis].
Fernández Salazar LI, Mateos Rodríguez JM, González Moreno L, Fernández Bermejo M, Pajares García JM.
Rev Clin Esp. 1999 Apr;199(4):258-9.
Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
D'Haens GR, Lashner BA, Hanauer SB.
Am J Gastroenterol. 1993 Aug;88(8):1174-8.
